AVE 16.7% 0.3¢ avecho biotechnology limited

time to change, page-6

  1. 1,388 Posts.
    I think Aveum will forge ahead over the next few years.
    Great management, good portfolio, good development pipe.

    + I think the kicker for this one is that it has such a good reputation in the provision of aged care that I think it will have an edge should some of the larger not
    for profit groups want to sell down some of their portfolios.

    If only I had some spare cash lying around I would buy more.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.